APOA4 | Apolipoprotein A-IV | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOB | Apolipoprotein B | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
BDH1 | 3-hydroxybutyrate dehydrogenase, type 1 | Candidate cardiovascular disease genes Enzymes Mitochondrial proteins
| | | | | Expressed in all |
CTSB | Cathepsin B | Cancer-related genes Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
ENG | Endoglin | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ENO3 | Enolase 3 (beta, muscle) | Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enriched |
F13A1 | Coagulation factor XIII, A1 polypeptide | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
F3 | Coagulation factor III (thromboplastin, tissue factor) | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
FAS | Fas cell surface death receptor | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
FGF2 | Fibroblast growth factor 2 (basic) | Cancer-related genes Candidate cardiovascular disease genes FDA approved drug targets RAS pathway related proteins
| | | | | Mixed |
IL18 | Interleukin 18 (interferon-gamma-inducing factor) | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins
| | | | | Expressed in all |
IL6ST | Interleukin 6 signal transducer (gp130, oncostatin M receptor) | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ITGA2B | Integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
LRP1 | Low density lipoprotein receptor-related protein 1 | Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
MYH11 | Myosin, heavy chain 11, smooth muscle | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Mixed |
MYH6 | Myosin, heavy chain 6, cardiac muscle, alpha | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Tissue enriched |
MYH7 | Myosin, heavy chain 7, cardiac muscle, beta | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Group enriched |
PYGB | Phosphorylase, glycogen; brain | Candidate cardiovascular disease genes Enzymes Plasma proteins
| | | | | Expressed in all |
S100B | S100 calcium binding protein B | Cancer-related genes Candidate cardiovascular disease genes
| | | | | Group enriched |
SELP | Selectin P (granule membrane protein 140kDa, antigen CD62) | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Mixed |
VEGFA | Vascular endothelial growth factor A | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Expressed in all |